These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32556779)

  • 1. Assessing the Effects of Holling Type-II Treatment Rate on HIV-TB Co-infection.
    Tanvi ; Aggarwal R; Kovacs T
    Acta Biotheor; 2021 Mar; 69(1):1-35. PubMed ID: 32556779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling HIV/AIDS and tuberculosis coinfection.
    Bhunu CP; Garira W; Mukandavire Z
    Bull Math Biol; 2009 Oct; 71(7):1745-80. PubMed ID: 19475456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
    Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
    J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment.
    Sharomi O; Podder CN; Gumel AB; Song B
    Math Biosci Eng; 2008 Jan; 5(1):145-74. PubMed ID: 18193936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of multiple
    Kyi MS; Palittapongarnpim P; Chaiprasert A; Ajawatanawong P; GarcIa HCG; Chongsuvivatwong V
    Int J Mycobacteriol; 2018; 7(4):375-379. PubMed ID: 30531038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state.
    Duffy FJ; Thompson EG; Scriba TJ; Zak DE
    PLoS One; 2019; 14(7):e0219322. PubMed ID: 31306460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical Analysis of the Transmission Dynamics of HIV Syphilis Co-infection in the Presence of Treatment for Syphilis.
    Nwankwo A; Okuonghae D
    Bull Math Biol; 2018 Mar; 80(3):437-492. PubMed ID: 29282597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of screening and treatment in the transmission dynamics of HIV/AIDS and tuberculosis co-infection: a mathematical study.
    Kaur N; Ghosh M; Bhatia SS
    J Biol Phys; 2014 Mar; 40(2):139-66. PubMed ID: 24664795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection.
    Bell LCK; Noursadeghi M
    Nat Rev Microbiol; 2018 Feb; 16(2):80-90. PubMed ID: 29109555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fractional order HIV-TB co-infection model in the presence of exogenous reinfection and recurrent TB.
    A T; Aggarwal R; Raj YA
    Nonlinear Dyn; 2021; 104(4):4701-4725. PubMed ID: 34075277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and associated factors for delayed presentation for HIV care among tuberculosis/HIV co-infected patients in Southwest Ethiopia: a retrospective observational cohort.
    Gesesew H; Tsehaineh B; Massa D; Tesfay A; Kahsay H; Mwanri L
    Infect Dis Poverty; 2016 Nov; 5(1):96. PubMed ID: 27802839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis and HIV co-infection-focus on the Asia-Pacific region.
    Trinh QM; Nguyen HL; Nguyen VN; Nguyen TV; Sintchenko V; Marais BJ
    Int J Infect Dis; 2015 Mar; 32():170-8. PubMed ID: 25809776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between antiretroviral therapy and antitubercular drug resistance in TB treatment outcome among Kazakh TB/HIV co-infected patients.
    Mishkin K; Alaei K; Alikeyeva E; Paynter C; Aringazina A; Alaei A
    J Glob Antimicrob Resist; 2018 Sep; 14():104-108. PubMed ID: 29496619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving survival with tuberculosis & HIV treatment integration: A mini-review.
    Naidoo K; Rampersad S; Karim SA
    Indian J Med Res; 2019 Aug; 150(2):131-138. PubMed ID: 31670268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges of TB and HIV co-treatment: updates and insights.
    Tornheim JA; Dooley KE
    Curr Opin HIV AIDS; 2018 Nov; 13(6):486-491. PubMed ID: 30080683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of HIV infection among tuberculosis patients in Eastern India.
    Manjareeka M; Nanda S
    J Infect Public Health; 2013 Oct; 6(5):358-62. PubMed ID: 23999356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-TB Coinfection: Current Therapeutic Approaches and Drug Interactions.
    Navasardyan I; Miwalian R; Petrosyan A; Yeganyan S; Venketaraman V
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic outcomes of anti-tuberculosis treatment in the context of HIV-tuberculosis co-infection: Cohort of Kabinda Center in Kinshasa, Democratic Republic of Congo].
    Akilimali PZ; Tshilumbu JM; Mavila AK; Kaba DK
    Rev Epidemiol Sante Publique; 2015 Dec; 63(6):387-93. PubMed ID: 26547669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.